Pharmaceuticals company Acutaas Chemicals announced Q1FY26 results Revenue from operations for Q1FY26 grew by 17.3% YoY to Rs 2,072 million The gross margin for the quarter improved to 53.2% up 1,117 bps YoY EBITDA for the quarter came at Rs 509 million up 72.4% YoY EBITDA margin for the quarter was at 24.6% as compared to 16.7% in Q1FY25 PAT for the quarter was Rs 440 million up 199.6% as compared to PAT of Rs 147 million in Q1FY25 The PAT margin for the quarter was at 21.2% up 1,292 bps YoY Export for the quarter at 60%; domestic business at 40% Naresh Patel, Executive Chairman & Managing Director, Ami Organics, said: “I am happy to share that we’ve had a strong start to FY26, with Q1 revenue growing 17.3% year-on-year, driven by robust performance in our Pharmaceutical Intermediates business. Both our pharma facilities are now PMDA GMP certified, underscoring our commitment to global compliance and quality. I am happy to announce that we have entered into a joint venture in South Korea which brings us closer to key semiconductor markets and strengthens our portfolio with differentiated, high-value products tailored for this space. With rising customer engagement across COMO, battery chemicals, and semiconductors, we step into FY26 with strong momentum and confidence to deliver 25% growth with improved margins.” Result PDF